SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form SC 13G/A - Statement of Beneficial Ownership by Certain Investors: [Amend]
SEC Accession No. 0001193125-20-033448
Filing Date
2020-02-13
Accepted
2020-02-12 17:38:03
Documents
2
Group Members
NEW LEAF BIOPHARMA OPPORTUNITIES II, L.P.NEW LEAF BPO ASSOCIATES II, L.P.NEW LEAF BPO MANAGEMENT II, L.L.C.NEW LEAF VENTURE ASSOCIATES II, L.P.NEW LEAF VENTURE MANAGEMENT II, L.L.C.RONALD M. HUNTVIJAY K. LATHI

Document Format Files

Seq Description Document Type Size
1 SC 13G/A d880640dsc13ga.htm SC 13G/A 145704
2 EX-99.2 d880640dex992.htm EX-99.2 14184
  Complete submission text file 0001193125-20-033448.txt   161720
Mailing Address 420 LEXINGTON AVENUE, SUITE 408 NEW YORK NY 10170
Business Address 420 LEXINGTON AVENUE, SUITE 408 NEW YORK NY 10170 (646) 871-6400
New Leaf Ventures II, L.P. (Filed by) CIK: 0001441439 (see all company filings)

IRS No.: 320214549 | State of Incorp.: DE | Fiscal Year End: 1231
Type: SC 13G/A

Mailing Address 400 EAST JAMIE COURT, SUITE 302 SOUTH SAN FRANCISCO CA 94080
Business Address 400 EAST JAMIE COURT, SUITE 302 SOUTH SAN FRANCISCO CA 94080 (650) 416-7700
Principia Biopharma Inc. (Subject) CIK: 0001510487 (see all company filings)

IRS No.: 263487603 | State of Incorp.: DE | Fiscal Year End: 1231
Type: SC 13G/A | Act: 34 | File No.: 005-90643 | Film No.: 20605746
SIC: 2834 Pharmaceutical Preparations